MyCelx Technologies Corporation Middle East Contract Win (0660P)
October 14 2021 - 2:00AM
UK Regulatory
TIDMMYX TIDMTTM
RNS Number : 0660P
MyCelx Technologies Corporation
14 October 2021
14 October 2021
The information contained within this announcement is deemed by
the Company to constitute inside information as stipulated under
the Market Abuse Regulations (EU) No. 596/2014 ("MAR").
MYCELX TECHNOLOGIES CORPORATION (AIM: MYX)
Middle East Contract Win
MYCELX Technologies Corporation ("MYCELX" or the "Company"), the
clean water and air technology company transforming the
environmental impact of industry, is pleased to announce a second
significant contract win in the Middle East this year.
This win supplements the four contract renewals awarded year to
date and provides further evidence of both an improving market but
also the continuing excellence of the MYCELX product suite. MYCELX
is the technology of choice as it provides superior performance and
reliability, and the Company's expertise and valuable client
support has been well-established over the ten years that MYCELX
has been operating in Saudi Arabia. Crucially, and in keeping with
the relationships in place, it is very cost effective.
Once again, MYCELX is providing a clean water solution to a
global blue-chip company in a part of the world where water is a
scarce commodity. Not only is the business providing the customer
with further credentials to allow them to enhance their ESG
requirements, but it is also of benefit to the local community.
The revenues for this contract of approximately $1million USD
will primarily fall in the 2022 financial year and thus provides
the Company with further financial visibility.
Connie Mixon, CEO of MYCELX, said:
"This is a real testament to the hard work and dedication shown
by our team in the Middle East as well as the enduring
relationships that they have with our customers. We are delighted
with this contract and look forward to updating our shareholders
with further news in due course."
For further information, please contact:
MYCELX Technologies Corporation
Connie Mixon, CEO Tel: +1 888 306 6843
Kim Slayton, CFO
Canaccord Genuity Limited (Nomad and Sole Broker)
Henry Fitzgerald-O'Connor Tel: +44 20 7523 8000
Georgina McCooke
Celicourt Communications (Financial PR)
Mark Antelme Tel: +44 20 8434 2754
Jimmy Lea
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
CNTFFMSILEFSESS
(END) Dow Jones Newswires
October 14, 2021 02:00 ET (06:00 GMT)
Mycelx Technologies (LSE:MYX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Mycelx Technologies (LSE:MYX)
Historical Stock Chart
From Jul 2023 to Jul 2024